Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

iSERA Lifesciences Annual General Meeting

iSERA Lifesciences Limited conducted its 34th Annual General Meeting on 29th September 2026, where shareholders adopted the audited financial statements and re-appointed a director.

Source

BSE filing, NSE: COVIDH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

iSERA Lifesciences Ltd: key numbers

Share price
₹143.90
Market cap
₹121.0 Cr
Revenue (annual)
₹1.36 Cr
Net profit (annual)
₹0.26 Cr
P/E (TTM)
466.5×Sector 22.9×
Promoter holding
55.07%-3.56% QoQ
FII holding
0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from iSERA Lifesciences Ltd

All →

Other annual general meeting announcements

All →